Greenland Mines Ltd (GRMLW) Stock Analysis
NASDAQBasic MaterialsOther Precious Metals
What Greenland Mines Ltd does
Greenland Mines Ltd. specializes in developing innovative treatments for neurodegenerative disorders. Their therapeutic pipeline includes both cell and gene therapies. Joseph Sinkule established the company on August 2, 2004, and it is presently headquartered in Omaha, Nebraska.
Key metrics
ETFs linked to GRMLW
Broad-market and Basic Materials sector ETFs an investor holding Greenland Mines Ltd is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how GRMLW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze GRMLW in PortView →Frequently asked questions
- What is the ticker symbol for Greenland Mines Ltd?
- Greenland Mines Ltd trades under the ticker GRMLW on NASDAQ.
- Which exchange is GRMLW listed on?
- GRMLW is listed on NASDAQ.
- What sector does Greenland Mines Ltd operate in?
- Greenland Mines Ltd is classified in the Basic Materials sector (Other Precious Metals industry).
- How can PortView help analyze GRMLW in a portfolio?
- PortView shows GRMLW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.